CTRI/2018/05/014006尚未招募未知
Randomized controlled double masked crossover trial comparing Kangaroo Mother Care and Sucrose in Reducing Pain in Preterm Neonates on Heel Prick
Charutar Arogya Mandal0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •28-36 weeks gestation neonates
排除标准
- •1.Neonates on ventilator
- •2. Clinically evident abnormal neurological signs
- •3. Have received analgesics/sedatives within last 24 h.
研究者
相似试验
招募中
不适用
A Randomized,Double Masked, Crossover Trial To Evaluate Safety And Efficacy Of Imported And Local Made Contact Lens For Refractive Error Correction In Mettapracharak (Wat Rai Khing) Hospital, Nakorn Pathom Provincedioptersafety and efficacy of local made contact lens and imported contact lens and also subjective acceptance of these contact lensrefractive error,Polyhema,contact lens,subjective acceptance,safety,visual acuity,keratometry,TCTR20161009002Dueba contact lens company limited40
已完成
不适用
A trial to compare a new contact lens solution with COMPLETE [Registered trade mark] Easy Rub [Registered trade mark] and renu [Registered trade mark] fresh [Trademark], when two commercially available contact lenses are worn in opposite eyes over two and eight hoursContact lens wearEye - Diseases / disorders of the eyeACTRN12611000586910Abbott Medical Optics, Inc55
进行中（未招募）
1 期
A randomised double blind controlled crossover trial of intravenous taurine supplementation in parenteral nutrition as an effective treatment for reducing hepatobiliary complications in chronic intestinal failure. - taurine in HPEUCTR2005-000680-26-GBorth west London Hospital Trust24
已完成
不适用
A double blind randomised controlled crossover trial of radiofrequency annuloplasty for the treatment of low back paiISRCTN42725861Department of Health (UK)
进行中（未招募）
1 期
Study to evaluate the efficacy, safety, tolerability and the extent to which the study drug is distributed in the body of multiple doses of QR-110 in subjects with LCA10 compared to a sham procedure. The study will be double-masked, randomized and controlled which means that both patients and study staff will not know and cannot influence who receives which treatment (study drug of sham).EUCTR2018-003501-25-ITPROQR THERAPEUTICS N.V.30